Evidence map›Paper›PMID 41461707›Full record

ArticleScientific reports2025

Auditory genotype-phenotype correlation of patients with variants in STRC.

Tae Uk Cheon, Sun Young Joo, Sung Huhn Kim, Jae Young Choi, Dongju Won, Heon Yung Gee, Jinsei Jung

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tae Uk CheonDepartment of Otorhinolaryngology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Sun Young JooWon-Sang Lee Institute for Hearing Loss, Seoul, Republic of Korea.
Sung Huhn KimWon-Sang Lee Institute for Hearing Loss, Seoul, Republic of Korea.
Jae Young ChoiWon-Sang Lee Institute for Hearing Loss, Seoul, Republic of Korea.
Dongju WonDepartment of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
Heon Yung GeeWon-Sang Lee Institute for Hearing Loss, Seoul, Republic of Korea.
Jinsei JungWon-Sang Lee Institute for Hearing Loss, Seoul, Republic of Korea. jsjung@yuhs.ac.

Funding

National Research Foundation of Korea grants RS-2024-00346485 and RS-2025-18362970the Ministry of Health & Welfare, Republic of Kor RS-2024-00404555 to J.J., and RS-2024-00439403
6 · The paper itself

Abstract

Pathogenic variants in the STRC gene are among the most common causes of autosomal recessive non-syndromic hearing loss, particularly in cases with mild-to-moderate sensorineural hearing loss (SNHL). Despite its prevalence, the clinical phenotype and natural history of STRC-related SNHL remain undercharacterized due to diagnostic challenges posed by a highly homologous pseudogene, pSTRC. This study included 23 families enrolled in the Yonsei University Hearing Loss cohort. Genetic testing was performed using either targeted deafness gene panels or whole-exome sequencing, followed by multiplex ligation-dependent probe amplification and confirmatory Sanger sequencing. A total of 23 patients with STRC-related SNHL were identified, including 12 with homozygous STRC/CATSPER2 gene deletions and 11 with other combinations of pathogenic variants. Most patients exhibited mild-to-moderate SNHL with flat or gently sloping audiometric configurations, predominantly affecting mid-to-high frequencies. No significant differences in mean PTA thresholds were observed between the two genotypic groups. Longitudinal analysis over a follow-up period of up to 4 years demonstrated stable hearing thresholds in 75% of ears, with no significant progression detected using linear mixed model analysis. Linear regression showed no age-dependent threshold shift in either ear across all genotypic subgroups. In conclusion, STRC-related hearing loss is typically mild-to-moderate, stable over time, and audiometrically similar regardless of genotypic subclassification. Given its subtle phenotype and diagnostic complexity, STRC mutations may be underrecognized without targeted screening. Incorporating STRC-specific MLPA assay into routine genetic diagnostics in patients with mild-to-moderate hearing loss may improve early detection and guide timely precision intervention.

Indexed as

Genetic Association StudiesHearing Loss, SensorineuralMembrane ProteinsAdolescentAdultChildChild, PreschoolFemaleGenetic TestingGenotypeHumansIntercellular Signaling Peptides and ProteinsMaleMiddle AgedMutationPhenotypeIntercellular Signaling Peptides and ProteinsMembrane ProteinsSTRC protein, humanCNVGenetic hearing lossGenotype-phenotype correlationLoss-of-functionStable hearing lossSTRC

Identifiers

PMID41461707
PMCPMC12749329

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.